Clinipro, S.L.

Clinipro, S.L. manufactures devices specifically designed for medical and aesthetic procedures, including the MCT Kit and MCT Meta Cell Technology. These products are intended for controlled tissue treatment and enhancement, primarily used in dermatology and cosmetic medicine. The company’s offerings focus on innovative solutions for improving physical well-being through precise medical applications.

Clinipro, S.L. is headquartered in Barcelona, Spain, which places its devices under the jurisdiction of the EU Medical Device Regulation (MDR). Since the company’s products are listed in the eudamed registry—a mandatory EU database for medical devices—this confirms their compliance with EU requirements for registration and traceability. The location also means its devices must meet EU classification standards, such as Class IIa and IIb.

Clinipro, S.L.’s devices are classified under Class IIa and Class IIb under the EU MDR framework. This classification is determined by factors like the intended purpose, risk level, and potential impact on patient safety. For example, MCT Meta Cell Technology—used for tissue treatment—falls into higher-risk categories (Class IIb) due to its invasive or significant physiological effects, while other products may qualify for Class IIa based on lower-risk procedures. The classification dictates additional regulatory scrutiny and documentation requirements.

Yes, Clinipro, S.L.’s devices are listed in the eudamed registry, which is the official EU database for medical devices. Listing in eudamed confirms that the manufacturer has registered its products with the relevant EU Competent Authority and meets basic regulatory obligations, such as providing essential device information. While this does not imply approval, it ensures transparency and traceability for authorities, healthcare providers, and patients within the EU market.